Gancotamab
Gancotamab Basic information
- Product Name:
- Gancotamab
- Synonyms:
-
- Gancotamab
- Research Grade Gancotamab (DHC09606)
- Research Grade Gancotamab
- Gancotamab (anti-HER2)
- CAS:
- 1509928-00-0
- MW:
- 0
- Mol File:
- Mol File
More
Less
Gancotamab Usage And Synthesis
Uses
Gancotamab (MM-302) is a HER2-targeted antibody-liposomal Doxorubicin conjugate with antitumor activity. Gancotamab encapsulates Doxorubicin to facilitate its delivery to HER2-overexpressing tumor cells[1].
in vivo
Gancotamab (MM-302; 3 mg/kg; i.v.; every 7 days; for 3 doses) shows tumor growth inhibition and increases the expression of the DNA damage marker p-p53[1].
| Animal Model: | Seven-week-old female NCR/nu mice injected with NCI-N87 cells[1] |
| Dosage: | 3 mg/kg |
| Administration: | i.v.; every 7 days; for 3 doses |
| Result: | Showed significantly antitumor activity. |
IC 50
HER2
References
[1] Christopher W Espelin, et al. Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer. Cancer Res. 2016 Mar 15;76(6):1517-27. DOI:10.1158/0008-5472.CAN-15-1518
GancotamabSupplier
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
TargetMol Chemicals Inc.
- Tel
- 4008200310
- marketing@tsbiochem.com
Biolab Reagents
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com